Metraipolis › archive › dc_cf3681598971

Enhancer-based gene therapy: a new path for precision medicine — Europe PMC PMID:41862973

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41862973
DOI
10.1186/s41065-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-04T03:09:25.797Z
SHA-256 of the archived text
2973ab1bd9ddd35213ea22e0a960c9bac10b86c78e6ceac7e9bc7745e5e2636a
Stable URL of this page
https://metraipolis.com/documento/dc_cf3681598971

How to cite

Enhancer-based gene therapy: a new path for precision medicine — Europe PMC PMID:41862973 — Europe PMC (en), https://europepmc.org/article/MED/41862973 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cf3681598971 (Metraipolis archive dc_cf3681598971, sha256 2973ab1bd9ddd35213ea22e0a960c9bac10b86c78e6ceac7e9bc7745e5e2636a)
BibTeX
@misc{dccf3681598971,
  title = {Enhancer-based gene therapy: a new path for precision medicine — Europe PMC PMID:41862973},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41862973},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cf3681598971; sha256 2973ab1bd9ddd35213ea22e0a960c9bac10b86c78e6ceac7e9bc7745e5e2636a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41862973. Agents can read the archived copy with the MCP tool read_document.